Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-03-02 @ 4:04 PM
Study NCT ID:
NCT02812420
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-05
First Post:
2016-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hydronephrosis | View |
| None | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | View |
| None | Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant | View |
| None | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | View |
| None | Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant | View |
| None | Renal Pelvis Urothelial Carcinoma | View |
| None | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | View |
| None | Stage II Renal Pelvis Cancer AJCC v7 | View |
| None | Stage II Ureter Cancer AJCC v7 | View |
| None | Stage II Urethral Cancer AJCC v7 | View |
| None | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | View |
| None | Stage III Renal Pelvis Cancer AJCC v7 | View |
| None | Stage III Ureter Cancer AJCC v7 | View |
| None | Stage III Urethral Cancer AJCC v7 | View |
| None | Stage IV Renal Pelvis Cancer AJCC v7 | View |
| None | Stage IV Ureter Cancer AJCC v7 | View |
| None | Stage IV Urethral Cancer AJCC v7 | View |
| None | Ureter Urothelial Carcinoma | View |
| None | Urethral Urothelial Carcinoma | View |
Keywords: